Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bloomer

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 26, 1981
On the three-dimensional structure and catalytic mechanism of triose phosphate isomeraseT Alber, D W Banner, A C Bloomer, et al.
Current Drug Metabolism|April 14, 2006
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolationF Ghanbari, K Rowland-Yeo, J C Bloomer, et al.
European Journal of Biochemistry|June 2, 1986
Oligonucleotide binding to the coat protein disk of tobacco mosaic virus. Possible steps in the mechanism of assemblyD R Turner, A Mondragon, L Fairall, et al.
Addiction Biology|January 7, 2016
Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairmentsV DI Sclafani, D L Truran, C Bloomer, et al.
Archives of General Psychiatry|April 25, 2001
Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cuesM S George, R F Anton, C Bloomer, et al.
BMC Pharmacology & Toxicology|June 21, 2015
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjectsBruce E Miller, Sunil Mistry, Kevin Smart, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 8, 2014
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteersBruce E Miller, Kevin Smart, Sunil Mistry, et al.
Nature Structural Biology|April 1, 1996
Three dimensional structure of human C-reactive proteinA K Shrive, G M Cheetham, D Holden, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1994
Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosingS E Clarke, N E Austin, J C Bloomer, et al.
Pharmaceutical Research|October 30, 2020
Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PKRichard S Lloyd, Martin I Hingle, Jackie C Bloomer, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 26, 1981
On the three-dimensional structure and catalytic mechanism of triose phosphate isomeraseT Alber, D W Banner, A C Bloomer, et al.
Current Drug Metabolism|April 14, 2006
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolationF Ghanbari, K Rowland-Yeo, J C Bloomer, et al.
European Journal of Biochemistry|June 2, 1986
Oligonucleotide binding to the coat protein disk of tobacco mosaic virus. Possible steps in the mechanism of assemblyD R Turner, A Mondragon, L Fairall, et al.
Addiction Biology|January 7, 2016
Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairmentsV DI Sclafani, D L Truran, C Bloomer, et al.
Archives of General Psychiatry|April 25, 2001
Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cuesM S George, R F Anton, C Bloomer, et al.
BMC Pharmacology & Toxicology|June 21, 2015
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjectsBruce E Miller, Sunil Mistry, Kevin Smart, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 8, 2014
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteersBruce E Miller, Kevin Smart, Sunil Mistry, et al.
Nature Structural Biology|April 1, 1996
Three dimensional structure of human C-reactive proteinA K Shrive, G M Cheetham, D Holden, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1994
Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosingS E Clarke, N E Austin, J C Bloomer, et al.
Pharmaceutical Research|October 30, 2020
Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PKRichard S Lloyd, Martin I Hingle, Jackie C Bloomer, et al.
Pageof 6